Bioventus Inc. (BVS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 11.25 |
| Open | 11.30 |
| Bid | 12.10 x 100 |
| Ask | 12.16 x 100 |
| Day's range | 11.27 - 12.25 |
| 52-week range | 2.88 - 12.41 |
| Volume | |
| Avg. volume | 579,295 |
| Market cap | 790.717M |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Bioventus Inc (BVS) reports a robust 14% organic revenue growth and outlines strategic plans to enhance core business focus.
- Zacks
ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
Data from a late-stage study shows that AbbVie's tavapadon reduced the burden of Parkinson's disease. The drug previously demonstrated efficacy as adjunctive therapy.
- Zacks
Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market
PFE's decision is based on clinical data, which suggests that the overall benefit of the drug no longer outweighs the risk in the approved patient population.
© 2024 Yahoo. All rights reserved.